Latest California Healthline Stories
State Lawmakers Eye Federal Dollars To Boost Mental Health Counseling By Peers
Medicaid pays for mentoring of mental health patients by “peer supporters,” but only if they are state-certified. California is one of two states with no certification program. Legislation pending in Sacramento would change that — if the governor backs it.
In Secret, Seniors Discuss ‘Rational Suicide’
Running counter to the efforts of suicide prevention experts and many religious and social norms, some seniors are quietly exploring the option of turning to suicide when they feel they’ve lived long enough.
En secreto, adultos mayores hablan del “suicidio racional”
Es un tema tabú, pero algunos adultos mayores comienzan a hablarlo. Se trata de la posibilidad de terminar con sus vidas pero no por depresión o desesperación, sino como una decisión pensada.
Meth In The Morning, Heroin At Night: Inside The Seesaw Struggle of Dual Addiction
Many users now mix opioids with stimulants like meth and cocaine — and researchers believe opioids kicked off this new stimulant wave.
Por qué muchos médicos no pueden dar malas noticias a pacientes y familiares
La palabra muerte parece estar prohibida en el vocabulario de muchos médicos que, justamente, deben lidiar con pacientes terminales. El resultado puede causar más dolor.
Never Say ‘Die’: Why So Many Doctors Won’t Break Bad News
It’s never easy to tell a patient about a terminal illness, but a longtime doctor whose own diagnosis was botched says physicians must do better.
Federal Grants ‘A Lifesaver’ In Opioid Fight, But States Still Struggle To Curb Meth
The federal government has doled out at least $2.4 billion in state grants since 2017 to address the opioid epidemic, which killed 47,600 people in the U.S. that year alone. But local officials note that drug abuse problems seldom involve only one substance.
Readers And Tweeters: No Rush To Judge Patients Who Leave The ER Without OK
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
Drug Users Armed With Naloxone Double As Medics On Streets Of San Francisco
The widespread availability of naloxone, which reverses overdoses, has radically changed the culture of opioid use on the streets, giving drug users a sense of security and inducing them to seek out the more powerful high of the synthetic opioid fentanyl.